-transparent.png){kind=logo}
The specific binding of [3H]PK 11195 to the peripheral-type benzodiazepine binding site is inhibited by the l-enantiomer of N,N-diethyl-alpha-methyl-2-phenyl-4-quinolinepropanamide ((-)Q1) but not by its d-enantiomer ((+)Q1). (-)Q1 inhibited [3H]PK 11195 binding to several rat tissues with an IC50 of less than 10 nM whereas (+)Q1 was at least 500 times less potent. This stereoselectivity was observed in all the tissues tested (brain, heart, kidney and adrenals). The same stereoselectivity was found for the displacement of the binding of [3H]PK 11195 in vivo, where (-)Q1 had an ID50 between 4-15 mg/kg and (+)Q1 was completely inactive at all doses tested (i.e. up to 40 mg/kg). Neither isomer had appreciable affinity for central-type benzodiazepine binding sites ([3H]diazepam) nor for voltage-sensitive calcium channels ([3H]PN 200210 and [3H]verapamil).
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
June 1987,
Neuropharmacology,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
January 1985,
Biochemical pharmacology,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
January 1988,
Life sciences,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
November 1983,
Archives internationales de pharmacodynamie et de therapie,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
January 1987,
Brain research bulletin,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
August 1983,
Life sciences,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
December 1983,
Journal of neurochemistry,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
January 1987,
Fundamental & clinical pharmacology,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
August 1984,
Biochemical pharmacology,
M C Dubroeucq, and
J Bénavidès, and
A Doble, and
F Guilloux, and
D Allam, and
N Vaucher, and
P Bertrand, and
C Guérémy, and
C Renault, and
A Uzan
July 1992,
Brain research,
